Elsevier

Journal of Hepatology

Volume 11, Issue 3, November 1990, Pages 385-387
Journal of Hepatology

Rapid publication
Genetic basis of nonresponse to hepatitis B vaccine in hemodialyzed patients

https://doi.org/10.1016/0168-8278(90)90226-HGet rights and content

Abstract

Genetic factors are implicated in the response of normal subjects to hepatitis B vaccine. The aim of our study was to investigate if HLA Class I and II proteins could participate in a nonresponse to this vaccine in immunocompromised, namely hemodialyzed, patients. One hundred and seven hemodialyzed patients (68 men and 39 women, mean age 35 years) were vaccinated with Pasteur Hevac B vaccine, with a mean delay of 2 months following the onset of chronic hemodialysis. Patients were considered nonresponders when their serum antiHBs remained < 10 mUI/ml on at least two occasions within the 12 months following the vaccination. HLA-A, B and DR antigens were determined by complement-dependent microlymphotoxicity. Ninety patients (84%) were responders and 17 (16%) nonresponders. The HLA-A1, B8 and DR3 frequency was higher in nonresponders (35, 35 and 44%, respectively) than in responders (18, 4 and 14%, respectively). The extended haplotype HLA-A1, B8, DR3 was more frequent in the former (19%) than in the latter (2%) (p < 0.03). There was only one female within the nonresponders (6%) as compared to 37 (41%) in the responders (p < 0.05). We conclude that genetic determinants (sex and HLA markers) play a critical role in the induction of an antiHBs immune response in both immunoincompetent hemodialyzed patients and normal immunocompetent hosts.

References (12)

There are more references available in the full text version of this article.

Cited by (0)

View full text